Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00773721
Other study ID # MA131008
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2008
Est. completion date May 2009

Study information

Verified date February 2021
Source ResMed
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Obstructive sleep apnoea (OSA) is characterised by a partial or complete collapse of the upper airway during sleep. The treatment of choice for OSA is Continuous Positive Airway Pressure (CPAP). CPAP acts as a positive airway splint, delivering a fixed positive airway pressure to the upper airway via a tube and mask. Compliance, however, to therapy requires that the mask is suitably comfortable so as not to disturb sleep. A key contributor to comfort is the seal component of the mask system. Current mask seals are mainly silicone elastomers, which though well understood and accepted, are often uncomfortable. It is proposed to replace the solid elastomer with a soft polymer foam. The foam is highly porous, and has open cells at its surface. It is therefore more likely to accumulate biological material with repeated use. The current (silicone) material does not present any problematic bioburden issues. Therefore it is important to investigate whether the foam will present bioburden problems to patients, within specified usage parameters. The aims of this study therefore are: 1. to observe the rate of bacterial accumulation on foam mask seal material (polyether polyurethane,) 2. to determine the replacement interval for a foam mask seal, and 3. assess the comfort and function of a foam mask seal.


Description:

Test Units: The test unit is a foam seal component which directly replaces the patients existing silicone mask cushion, and is fitted to the patients existing mask frame. Subjects will wear the test unit mask, instead of the current CPAP mask, each night whilst sleeping. Upon waking, subjects will remove the test unit mask and place it with the skin contact side uppermost on a flat surface adjacent to their bed (e.g. a bedside table). Test unit masks should not be covered, and are to remain exposed to the bedroom environment for the rest of the day. The cycle repeats for up to 35 days (5 weeks). If necessary, the test can be terminated before this time. A control group of 2 subjects will wash their test unit mask with only hot water every day for the 5 weeks. Another 4 subjects will have the foam of their test unit mask replaced during the 5 weeks of the trial. Two subjects will have the foam changed after 2 weeks and the other 2 subjects after 4 weeks. This will allow estimations of bioburden after 1,2,3,4 and 5 weeks of use. The foam samples are to be sealed in the supplied sterile container. The sealed container will be delivered as soon as possible to the project administrator. The project administrator will appropriately collect, record, store, and dispatch the sealed samples for microbiological analysis. Microbial analysis will determine the number of colony forming units, and species present in each test unit upon test termination. Skin Reactions: Participants will be asked to report any skin reaction they experience under the test unit. Subjects will keep a bi-weekly record of any skin redness, irritation, etc.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date May 2009
Est. primary completion date December 2008
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Patients who are 18+ - Patients willing to give written informed consent - Patients who can read and comprehend English - Patients being treated for OSA with CPAP for >6 months - Patients using ResMed Masks Exclusion Criteria: - • Known to have any pre-existing dermatological condition - Has been treated with antibiotics in the previous month - Any condition which, in the opinion of the investigator, would make the subject unsuitable or unsafe for enrolment, or could interfere with the subject participating in and completing the protocol. - Patients currently using ResMed masks: Swift, Activa, or Liberty.

Study Design


Intervention

Device:
CPAP mask
Current CPAP masks are mainly silicone elastomers, which though well understood and accepted, are often uncomfortable. Test Units: The test unit is a foam seal component which directly replaces the patients existing silicone mask cushion, and is fitted to the patients existing mask frame. Subjects will wear the test unit mask, instead of their current CPAP mask, each night whilst sleeping.

Locations

Country Name City State
Australia Resmed Centre for Healthy Sleep Sydney New South Wales

Sponsors (1)

Lead Sponsor Collaborator
ResMed

Country where clinical trial is conducted

Australia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measurement of bacterial accumulation in the new material. up to 35 days (5 weeks).
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04939168 - Measuring Atomoxetine and Aroxybutynin In Patients With OSA Phase 2
Completed NCT02908529 - Atomoxetine and Oxybutynin in Obstructive Sleep Apnea Phase 1/Phase 2
Completed NCT03415633 - Validity of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea N/A
Completed NCT03426631 - DAW1033B2 in Obstructive Sleep Apnea Phase 1/Phase 2
Completed NCT04206449 - Sleep Thermography for Diagnosis of Obstructive Sleep Apnea (TERMOAPNEA) N/A
Active, not recruiting NCT03018912 - Validating the Use of a Subjectively Reported Sleep Vital Sign N/A
Completed NCT02549508 - Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD N/A
Completed NCT01249924 - The Effectiveness of Perioperative CPAP to Reduce Obstructive Sleep Apnea Related Adverse Events N/A
Completed NCT02314858 - Tailored Treatment to Enhance Risk Perception in Sleep Apnea N/A
Completed NCT01476917 - The ATLAST Long-Term Study Phase 2/Phase 3
Terminated NCT00730041 - Palatal Implants in Combination With Continuous Positive Airway Pressure to Treat Obstructive Sleep Apnea Phase 4
Completed NCT00850434 - Improved Automatic CPAP Algorithm to Treat Obstructive Sleep Apnea (OSA) N/A
Enrolling by invitation NCT04538755 - DAW2020 on OSA Endotypic Traits Phase 1/Phase 2
Completed NCT02501304 - Feasibility Study of the ReVENT Sleep Apnea System N/A
Withdrawn NCT02805777 - Vent Flow Study of Prototype Nasal CPAP Mask N/A
Completed NCT02097212 - Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep Apnea N/A
Active, not recruiting NCT02295306 - Overnight Polysomnography and Respiratory Volume Monitor
Completed NCT01939938 - Pilot Study of the Comparison of the Upper Airway Dynamics of Oronasal vs Nasal Masks With PAP Treatment N/A
Terminated NCT01877928 - Post-extubation Boussignac CPAP System in Adults With Moderate to Severe Obstructive Sleep Apnea N/A
Completed NCT00965783 - Predictors of the Metabolic Effect of Sleep Loss N/A